We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$121M
AUM Growth
+$5.47M
Cap. Flow
+$2.37M
Cap. Flow %
1.97%
Top 10 Hldgs %
31.38%
Holding
119
New
7
Increased
15
Reduced
17
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.32M
2
CAT icon
Caterpillar
CAT
+$1.06M
3
DEO icon
Diageo
DEO
+$1.05M
4
YUMC icon
Yum China
YUMC
+$943K
5
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$366K

Top Sells

Rank Stock Value
1
YUM icon
Yum! Brands
YUM
+$851K
2
GLD icon
SPDR Gold Trust
GLD
+$822K
3
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$726K
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$455K
5
AMZN icon
Amazon
AMZN
+$284K

Sector Composition

Rank Sector Weight
1 Healthcare 22.31%
2 Energy 16.08%
3 Industrials 11.21%
4 Technology 11.01%
5 Financials 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKS
101
DELISTED
Oneok Partners LP
OKS
$258K 0.21%
+6,000
New +$249K
CB icon
102
Chubb
CB
$137B
$256K 0.21%
1,938
– –
DRI icon
103
Darden Restaurants
DRI
$22.7B
$255K 0.21%
3,500
– –
GIS icon
104
General Mills
GIS
$20.3B
$247K 0.2%
4,000
– –
PAA icon
105
Plains All American Pipeline
PAA
$16.8B
$245K 0.2%
7,600
– –
TGT icon
106
Target
TGT
$63.4B
$232K 0.19%
3,211
– –
TRGP icon
107
Targa Resources
TRGP
$60.7B
$231K 0.19%
+4,125
New +$208K
DGX icon
108
Quest Diagnostics
DGX
$23.3B
$230K 0.19%
2,500
– –
KO icon
109
Coca-Cola
KO
$351B
$228K 0.19%
5,508
– –
IVV icon
110
iShares Core S&P 500 ETF
IVV
$881B
$214K 0.18%
950
– –
CMCSA icon
111
Comcast
CMCSA
$85B
$204K 0.17%
+5,902
New +$197K
ET icon
112
Energy Transfer Partners
ET
$69.9B
$193K 0.16%
10,000
– –
AVP
113
DELISTED
Avon Products, Inc.
AVP
$91K 0.08%
18,000
– –
AMZN icon
114
Amazon
AMZN
$2.66T
– –
-6,800
Closed -$284K
GLD icon
115
SPDR Gold Trust
GLD
$130B
– –
-5,796
Closed -$822K
PGNX
116
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-105,000
Closed -$726K
CGNT
117
DELISTED
Cogentix Medical, Inc.
CGNT
– –
-10,000
Closed -$18K
PTX
118
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-17,250
Closed -$105K
BDSI
119
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-184,250
Closed -$455K
1 2 3 4
5

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Searle & Co held 119 positions worth $121M, up 4.8% from $115M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Searle & Co's Q4 2016 filing shows 7 new, 15 increased, 17 reduced and 6 closed positions. Its largest new stake was Caterpillar: 11,641 shares worth $1.08M. The largest sale was Yum! Brands, an estimated $851K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Searle & Co's largest Q4 2016 buy was Caterpillar: 11,641 shares worth $1.08M.
  • Searle & Co added most to Bristol-Myers Squibb in Q4 2016, an estimated $1.32M increase.
  • Searle & Co's biggest Q4 2016 reduction was Yum! Brands, cutting an estimated $851K.
  • Searle & Co fully exited SPDR Gold Trust in Q4 2016, selling an estimated $822K.
  • Searle & Co's ten largest holdings make up 31% of its $121M portfolio in Q4 2016.
  • Searle & Co opened 7 new positions and closed 6 in Q4 2016.
  • Searle & Co's portfolio value rose 4.8% quarter-over-quarter to $121M.

Based on Searle & Co's 13F filing for Q4 2016, filed 9 Jan 2017.